Feedback / Questions
lirentelimab (AK002) - Allakos
http://clinicaltrials.gov/ct2/show/NCT03664960
Dec 21, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next